Cardlytics, Inc.CDLXNASDAQ
Loading
CDLX Revenue Growth (YoY Quarterly)•-24.19%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-24.19%
-1.8pp
-19.48%
-4.6pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+4.13%
-2.8pp
+4.13%
-2.8pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -17.01% | -8.45% | -9.17% | -22.41% | -24.19% |
| Gross Profit Growth | -17.11% | -18.55% | +1.90% | -14.89% | -19.48% |
| EBITDA Growth | +0.00% | +0.00% | -99.94% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +29.28% | +19.92% | +7.53% | +6.93% | +4.13% |
| Weighted Average Shares Diluted Growth | +29.28% | +19.92% | +7.53% | +6.93% | +4.13% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +1.53% | +0.00% | -72.34% | +27.24% | +336.72% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | -408.21% | +0.00% |
| Receivables Growth | -15.04% | -10.40% | -10.01% | -16.57% | -20.36% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -31.60% | -35.13% | -32.42% | -26.69% | -27.26% |
| Book Value per Share Growth | -59.83% | -73.16% | -74.01% | +0.00% | +0.00% |
| Debt Growth | -16.68% | -17.52% | -0.70% | -0.22% | -2.86% |
| R&D Expense Growth | -20.91% | -10.29% | -16.15% | -33.31% | -19.50% |
| SG&A Expenses Growth | -10.36% | -7.24% | -19.67% | -25.83% | -31.29% |
1 / 4